Atlas FDA

Barricaid Anular Closure Device (ACD)

FDA premarket approval P160050/S003 · decided 2020-03-17

Approval details

PMA number
P160050
Supplement
S003
Supplement type
Real-Time Process
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Barricaid Anular Closure Device (ACD)
Generic name
Reherniation reduction device
Applicant
Intrinsic Therapeutics
Date received
2019-03-19
Decision date
2020-03-17
Days to decision
364 days
Decision code
APPR
Product code
QES
Advisory committee
Orthopedic
Expedited review
No
Location
Woburn, MA
Statement
Approval to change the supplier and specifications of the polyester yarn used to make the mesh of the woven fabric for the flexible occlusion component of the Barricaid Anular Closure Device (ACD).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.